Mayflower Financial Advisors, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mayflower Financial Advisors, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$430,834
+40.2%
6,817
-0.2%
0.06%
+40.0%
Q1 2023$307,237
+3.1%
6,829
+0.4%
0.04%
-2.4%
Q4 2022$298,083
-33.6%
6,804
-0.1%
0.04%
-43.1%
Q3 2022$449,000
+30.5%
6,813
+0.1%
0.07%
+35.8%
Q2 2022$344,000
-25.2%
6,806
-5.5%
0.05%
-14.5%
Q1 2022$460,000
-40.3%
7,1990.0%0.06%
-39.2%
Q4 2021$771,000
+4.5%
7,1990.0%0.10%
+2.0%
Q3 2021$738,0007,1990.10%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders